| Kim, Hyung L |
Cedars-Sinai Medical Center
United States |
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer |
1R01CA280060-01A1 |
|
Howard L. Parnes, M.D. |
| Tangen, Catherine M. |
Fred Hutchinson Cancer Center
United States |
PCPT and SELECT Cohorts: Core Infrastructure Support for Cancer Research |
5U01CA182883-11 |
|
Howard L. Parnes, M.D. |
| Hansen, Laura A |
Creighton University
United States |
Targeting aberrant anti-apoptotic signaling for prevention of skin cancer |
5R01CA253573-05 |
|
Howard L. Parnes, M.D. |
| Svatek, Robert Scott |
University Of Texas Hlth Science Center
United States |
eRapa for bladder cancer prevention |
5R01CA252057-04 |
PAR-19-183 (R01 Clinical Trial Optional) |
Howard L. Parnes, M.D. |
| Linnes, Jacqueline |
Purdue University
United States |
Point-of-care screening test for early cervical cancer detection |
5R01CA246315-04 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Dhakal, Soma |
Virginia Commonwealth University
United States |
Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers |
5R61CA278445-02 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Wang, Tza-Huei Jeff |
Johns Hopkins University
United States |
Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women |
5R01CA260628-03 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Labaer, Joshua |
Arizona State University-Tempe Campus
United States |
High-throughput immunoproteomics for cancer biomarker discovery |
5U2CCA271903-02 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Figueiredo, Jane C. |
Cedars-Sinai Medical Center
United States |
Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2 |
3U54CA260591-02S3 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Linnes, Jacqueline |
Purdue University
United States |
Point-of-care screening test for early cervical cancer detection |
5R01CA246315-04 |
|
Christos Patriotis, Ph.D., M.Sc. |